![Kenneth Stauderman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth Stauderman
Gründer bei CALCIMEDICA, INC.
Vermögen: 67 842 $ am 31.05.2024
Aktive Positionen von Kenneth Stauderman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CALCIMEDICA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2007 | - |
Gründer | 01.04.2007 | - | |
CalciMedica, Inc. (US)
![]() CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2006 | - |
Gründer | 11.08.2009 | - |
Karriereverlauf von Kenneth Stauderman
Ehemalige bekannte Positionen von Kenneth Stauderman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TorreyPines Therapeutics, Inc.
![]() TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01.01.2000 | 01.01.2007 |
Sibia Neurosciences, Inc. | Corporate Officer/Principal | 01.01.1994 | 01.01.2000 |
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1986 | 01.01.1994 |
Marion Merrell Dow Pharmaceutical, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Kenneth Stauderman
University of Virginia | Undergraduate Degree |
Texas University of Health Center at San Antonio | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CALCIMEDICA, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
CalciMedica, Inc. (US)
![]() CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
TorreyPines Therapeutics, Inc.
![]() TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
Sibia Neurosciences, Inc. | Health Technology |
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Marion Merrell Dow Pharmaceutical, Inc. |
- Börse
- Insiders
- Kenneth Stauderman
- Erfahrung